UK livestock farmers have been warned not to purchase or sell bluetongue vaccine through online channels, according to a Farmers Guardian report. The advisory singles out a trade that bypasses authorised supply chains and exposes holdings to product of unverified origin and handling.

The warning arrives as bluetongue virus activity continues to shape movement and vaccination decisions on UK sheep and cattle units. BTV is a notifiable disease, with suspect cases reported to the Animal and Plant Health Agency (APHA). Vaccines against circulating serotypes remain prescription-only veterinary medicines in the UK, dispensed through veterinarians and approved wholesalers who maintain the cold chain the product requires.

What does the advisory cover?

The advisory targets any bluetongue vaccine transaction that does not pass through a registered veterinarian and an authorised distributor. That includes social-media listings, third-party online sellers, and peer-to-peer trade between farms. Veterinary medicines oversight in the UK sits with the Veterinary Medicines Directorate (VMD), which licenses products and inspects distributors.

The risks, in plain terms:

• Cold-chain failure. Modified-live bluetongue vaccines require strict temperature control from manufacturer to animal. A break in that chain can render a dose ineffective, and the buyer cannot verify handling history outside approved supply.
• Product identity. Vaccines sold without veterinary involvement cannot be confirmed as legitimate stock. Counterfeit, expired, or mishandled product remains a recurring concern across livestock-medicine categories.
• Legal exposure. Supplying a prescription-only veterinary medicine without authorisation is an offence under the Veterinary Medicines Regulations. Farmers advertising or selling product face enforcement action regardless of intent.

The registered route is the only route with regulatory standing.

What changes at the exam table?

Practitioners are the gatekeepers of the legitimate supply chain. Under the current UK framework, a vet must prescribe bluetongue vaccine within the farm health plan, with batch number, administration record, and animal identifier retained to VMD and APHA expectations. Vets should expect clients to ask about online offers and should be ready to explain why the registered route protects them.

Producers weighing cost savings from online listings should weigh the absence of recourse if the product fails. When the dose fails, the discount disappears.

What about companion animals, public health, and trade?

The advisory sits squarely in the food-animal column. Bluetongue does not infect dogs, cats, or horses; companion-animal practice is unaffected. From a public-health angle, BTV is not a recognised zoonosis, and human infection is not part of the disease picture. The concern is animal welfare, trade, and the integrity of disease control, not human risk.

Regulatory status and what to watch

Bluetongue vaccines authorised for UK use carry VMD marketing authorisations. Any product offered online without a traceable batch number, a UK-authorised pack, and a prescription pathway sits outside that authorisation. Producers or vets who become aware of unofficial supply can report through VMD reporting channels.

The advisory will weigh most heavily on holdings considering vaccination as part of outbreak-area operations. The forward-looking question is whether the warning holds informal-market demand down through the transmission season, or whether enforcement action follows.